In vitro inflammation and toxicity assessment of pre- and post-incinerated organomodified nanoclays to macrophages using high-throughput screening approaches

© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply..

BACKGROUND: Organomodified nanoclays (ONC), two-dimensional montmorillonite with organic coatings, are increasingly used to improve nanocomposite properties. However, little is known about pulmonary health risks along the nanoclay life cycle even with increased evidence of airborne particulate exposures in occupational environments. Recently, oropharyngeal aspiration exposure to pre- and post-incinerated ONC in mice caused low grade, persistent lung inflammation with a pro-fibrotic signaling response with unknown mode(s) of action. We hypothesized that the organic coating presence and incineration status of nanoclays determine the inflammatory cytokine secretary profile and cytotoxic response of macrophages. To test this hypothesis differentiated human macrophages (THP-1) were acutely exposed (0-20 µg/cm2) to pristine, uncoated nanoclay (CloisNa), an ONC (Clois30B), their incinerated byproducts (I-CloisNa and I-Clois30B), and crystalline silica (CS) followed by cytotoxicity and inflammatory endpoints. Macrophages were co-exposed to lipopolysaccharide (LPS) or LPS-free medium to assess the role of priming the NF-κB pathway in macrophage response to nanoclay treatment. Data were compared to inflammatory responses in male C57Bl/6J mice following 30 and 300 µg/mouse aspiration exposure to the same particles.

RESULTS: In LPS-free media, CloisNa exposure caused mitochondrial depolarization while Clois30B exposure caused reduced macrophage viability, greater cytotoxicity, and significant damage-associated molecular patterns (IL-1α and ATP) release compared to CloisNa and unexposed controls. LPS priming with low CloisNa doses caused elevated cathepsin B/Caspage-1/IL-1β release while higher doses resulted in apoptosis. Clois30B exposure caused dose-dependent THP-1 cell pyroptosis evidenced by Cathepsin B and IL-1β release and Gasdermin D cleavage. Incineration ablated the cytotoxic and inflammatory effects of Clois30B while I-CloisNa still retained some mild inflammatory potential. Comparative analyses suggested that in vitro macrophage cell viability, inflammasome endpoints, and pro-inflammatory cytokine profiles significantly correlated to mouse bronchioalveolar lavage inflammation metrics including inflammatory cell recruitment.

CONCLUSIONS: Presence of organic coating and incineration status influenced inflammatory and cytotoxic responses following exposure to human macrophages. Clois30B, with a quaternary ammonium tallow coating, induced a robust cell membrane damage and pyroptosis effect which was eliminated after incineration. Conversely, incinerated nanoclay exposure primarily caused elevated inflammatory cytokine release from THP-1 cells. Collectively, pre-incinerated nanoclay displayed interaction with macrophage membrane components (molecular initiating event), increased pro-inflammatory mediators, and increased inflammatory cell recruitment (two key events) in the lung fibrosis adverse outcome pathway.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:21

Enthalten in:

Particle and fibre toxicology - 21(2024), 1 vom: 21. März, Seite 16

Sprache:

Englisch

Beteiligte Personen:

Stueckle, Todd A [VerfasserIn]
Jensen, Jake [VerfasserIn]
Coyle, Jayme P [VerfasserIn]
Derk, Raymond [VerfasserIn]
Wagner, Alixandra [VerfasserIn]
Dinu, Cerasela Zoica [VerfasserIn]
Kornberg, Tiffany G [VerfasserIn]
Friend, Sherri A [VerfasserIn]
Dozier, Alan [VerfasserIn]
Agarwal, Sushant [VerfasserIn]
Gupta, Rakesh K [VerfasserIn]
Rojanasakul, Liying W [VerfasserIn]

Links:

Volltext

Themen:

Cathepsin B
Cytokines
EC 3.4.22.1
High-throughput screening
Human lung cells
In vitro models
Incineration
Interleukin-1beta
Journal Article
Lipopolysaccharides
Mouse
Nanoclay
Organic coating
Silicates

Anmerkungen:

Date Completed 22.03.2024

Date Revised 23.03.2024

published: Electronic

Citation Status MEDLINE

doi:

10.1186/s12989-024-00577-7

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369991966